Irina Dralyuk, MD, discusses how to best prevent vulnerable parties, especially children, from breathing in the toxic smoke in Los Angeles.

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) ...

RCT-2100 is under clinical development by Recode Therapeutics and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase II drugs for Cystic Fibrosis have a 31% phase transition ...

Situs inversus is a rare genetic condition that causes the organs in the chest and abdomen to be located on the opposite side ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug ...

Parkinson's disease is characterized by a collection of uniquely distinguishing symptoms that affect movement and a number of other aspects of daily life. These include, but are not limited to, ...

It is administered through inhalational route. The drug candidate is developed as a nebulized therapy. It was under development for primary ciliary dyskinesia (PCD), tracheostomy, cystic fibrosis, ...

The ophthalmic nerve is the first branch of the trigeminal nerve, which is also known as the fifth cranial nerve. The ophthalmic nerve supplies sensory innervation to the structures of the eye, ...

FRIDAY, Dec. 20, 2024 (HealthDay News) -- Most children with likely primary ciliary dyskinesia (PCD) have asthma, according to a research letter published online Dec. 9 in JAMA Network Open.

FRIDAY, Dec. 20, 2024 (HealthDay News) -- Most children with likely primary ciliary dyskinesia (PCD) have asthma, according to a research letter published online Dec. 9 in JAMA Network Open. Joe Zein, ...

A NEW study published revealed a strong association between primary ciliary dyskinesia (PCD) and asthma in children, suggesting that asthma should be routinely considered a comorbidity in patients ...